Original Article
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial
Eficacia y seguridad de hidroxicloroquina en profesionales sanitarios con infección leve por SARS-CoV-2: Estudio prospectivo y no aleatorio
Antonia Agustia,b, Elena Guillena,b, Alfonso Ayorac, Andres Antond,e, Cristina Aguileraa,b, Xavier Vidala,b, Cristina Andresd,e, Manuel Alonsoc, Meritxell Espugac, Juliana Esperalbad,e, Mª Queralt Gorgasb,f, Benito Almiranteg,h, Esteban Riberag,h,
Corresponding author
a Clinical Pharmacology Service, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain
b Departament de Farmacologia, Terapèutica I Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain
c Occupational Health Service, Vall d’Hebron Hospital Universitari, Barcelona, Spain
d Respiratory Viruses Unit, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain
e Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain
f Clinical Pharmacy Service, Vall d’Hebron Hospital Universitari, Barcelona, Spain
g Infectious Diseases Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain
h Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
Read
2496
Timeswas read the article
254
Total PDF
2242
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 14 | 14 | 28 |
| 2025 11 | 64 | 15 | 79 |
| 2025 10 | 47 | 11 | 58 |
| 2025 9 | 43 | 10 | 53 |
| 2025 8 | 39 | 7 | 46 |
| 2025 7 | 63 | 8 | 71 |
| 2025 6 | 50 | 6 | 56 |
| 2025 5 | 33 | 1 | 34 |
| 2025 4 | 45 | 6 | 51 |
| 2025 3 | 40 | 6 | 46 |
| 2025 2 | 32 | 5 | 37 |
| 2025 1 | 91 | 3 | 94 |
| 2024 12 | 77 | 5 | 82 |
| 2024 11 | 34 | 1 | 35 |
| 2024 10 | 25 | 2 | 27 |
| 2024 9 | 30 | 6 | 36 |
| 2024 8 | 35 | 5 | 40 |
| 2024 7 | 24 | 3 | 27 |
| 2024 6 | 36 | 3 | 39 |
| 2024 5 | 34 | 2 | 36 |
| 2024 4 | 37 | 8 | 45 |
| 2024 3 | 57 | 7 | 64 |
| 2024 2 | 36 | 1 | 37 |
| 2024 1 | 54 | 9 | 63 |
| 2023 12 | 51 | 1 | 52 |
| 2023 11 | 158 | 8 | 166 |
| 2023 10 | 112 | 8 | 120 |
| 2023 9 | 64 | 3 | 67 |
| 2023 8 | 130 | 0 | 130 |
| 2023 7 | 41 | 52 | 93 |
| 2023 6 | 51 | 1 | 52 |
| 2023 5 | 82 | 3 | 85 |
| 2023 4 | 58 | 2 | 60 |
| 2023 3 | 57 | 2 | 59 |
| 2023 2 | 39 | 9 | 48 |
| 2023 1 | 38 | 2 | 40 |
| 2022 12 | 56 | 13 | 69 |
| 2022 11 | 60 | 1 | 61 |
| 2022 10 | 54 | 5 | 59 |
| 2022 9 | 46 | 0 | 46 |
| 2022 8 | 45 | 0 | 45 |
| 2022 7 | 30 | 0 | 30 |
| 2022 6 | 30 | 0 | 30 |
Show all
